- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 5.47M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 752.46K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 134.33K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $104K |
| Capex | Q1 2026 · Mar 31, 2025 | $79K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $251K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.33M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $194K |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $215K |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $2.2M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $1.44M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $8.83M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $12.5M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.92M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.09M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $7.73M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $7.09M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.65M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.1M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $5.6M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.79M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $17.48M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $20.6M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$5.25 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$24.74 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.91M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $2.61M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.67M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.32M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$6.68M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.93M |
| Revenue | Q1 2026 · Mar 31, 2026 | $3.34M |
| Revenue | Q1 2026 · Mar 31, 2025 | $2.72M |